These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
505 related articles for article (PubMed ID: 23103194)
1. Rubella control in Papua New Guinea: age-specific immunity informs strategies for introduction of rubella vaccine. Riddell M; Senn N; Clements CJ; Hobday L; Cowie B; Kurubi J; Kevin A; Siba P; Reeder JC; Morgan C Vaccine; 2012 Dec; 30(52):7506-12. PubMed ID: 23103194 [TBL] [Abstract][Full Text] [Related]
2. The use of rapid coverage monitoring in the national rubella vaccination campaign, Haiti 2007-2008. Lacapère F; Magloire R; Danovaro-Holliday MC; Flannery B; Chamoulliet H; Celestin EP J Infect Dis; 2011 Sep; 204 Suppl 2():S698-705. PubMed ID: 21954269 [TBL] [Abstract][Full Text] [Related]
3. Haiti 2007-2008 national measles-rubella vaccination campaign: implications for rubella elimination. Rainey JJ; Danovaro-Holliday MC; Magloire R; Kananda G; Lee CE; Chamouillet H; Lacapere F; Mung K; Luman ET J Infect Dis; 2011 Sep; 204 Suppl 2():S616-21. PubMed ID: 21954256 [TBL] [Abstract][Full Text] [Related]
4. Rubella vaccination of unknowingly pregnant women during mass campaigns for rubella and congenital rubella syndrome elimination, the Americas 2001-2008. Castillo-Solórzano C; Reef SE; Morice A; Vascones N; Chevez AE; Castalia-Soares R; Torres C; Vizzotti C; Ruiz Matus C J Infect Dis; 2011 Sep; 204 Suppl 2():S713-7. PubMed ID: 21954271 [TBL] [Abstract][Full Text] [Related]
5. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996]. Zäch K; Nicoara C; Germann D; Matter L Schweiz Med Wochenschr; 1998 Apr; 128(17):649-57. PubMed ID: 9622837 [TBL] [Abstract][Full Text] [Related]
6. Congenital rubella syndrome in infants of women vaccinated during or just before pregnancy with measles-rubella vaccine. Namaei MH; Ziaee M; Naseh N Indian J Med Res; 2008 Jun; 127(6):551-4. PubMed ID: 18765873 [TBL] [Abstract][Full Text] [Related]
7. [Epidemiological analysis of immunity against vaccine-preventable diseases: rubella, measles, mumps and chickenpox]. Buxbaum S; Doerr HW; Allwinn R Dtsch Med Wochenschr; 2001 Nov; 126(46):1289-93. PubMed ID: 11709730 [TBL] [Abstract][Full Text] [Related]
9. Measles, mumps and rubella: control by vaccination. van Druten JA; de Boo T; Plantinga AD Dev Biol Stand; 1986; 65():53-63. PubMed ID: 3556777 [TBL] [Abstract][Full Text] [Related]
10. Progress in measles and rubella elimination in Iran. Esteghamati A; Gouya MM; Zahraei SM; Dadras MN; Rashidi A; Mahoney F Pediatr Infect Dis J; 2007 Dec; 26(12):1137-41. PubMed ID: 18043452 [TBL] [Abstract][Full Text] [Related]
11. Rubella seroprevalence among women of childbearing age residing in a rural region: is there a need for rubella vaccination in Turkey? Aksakal FN; Maral I; Cirak MY; Aygun R Jpn J Infect Dis; 2007 Jul; 60(4):157-60. PubMed ID: 17642522 [TBL] [Abstract][Full Text] [Related]
12. Prospective evaluation of pregnant women vaccinated against rubella in southern Brazil. Minussi L; Mohrdieck R; Bercini M; Ranieri T; Sanseverino MT; Momino W; Callegari-Jacques SM; Schuler-Faccini L Reprod Toxicol; 2008 Jan; 25(1):120-3. PubMed ID: 17977696 [TBL] [Abstract][Full Text] [Related]
13. [Morbidity, vaccine coverage and immunity against measles, mumps and rubella in a Gallician population from 2 to 5 years old]. Vázquez Fernández E; López Rois F; Vázquez Carrete JA; Gómez Tato B; Alvarez Ares M An Esp Pediatr; 1987 Jul; 27(1):27-31. PubMed ID: 3662251 [TBL] [Abstract][Full Text] [Related]
14. Pregnancy outcomes following rubella vaccination: a prospective study in the state of Rio de Janeiro, Brazil, 2001-2002. da Silva e Sá GR; Camacho LA; Stavola MS; Lemos XR; Basílio de Oliveira CA; Siqueira MM J Infect Dis; 2011 Sep; 204 Suppl 2():S722-8. PubMed ID: 21954273 [TBL] [Abstract][Full Text] [Related]
15. Immunogenicity of measles and rubella vaccines in Oman: a prospective clinical trial. Kohler KA; Suleiman AJ; Robertson SE; Malankar P; Al-Khusaiby S; Helfand RF; Brown D; Bellini WJ; Sutter RW J Infect Dis; 2003 May; 187 Suppl 1():S177-85. PubMed ID: 12721911 [TBL] [Abstract][Full Text] [Related]
16. Targeting rubella for elimination. Taneja DK; Sharma P Indian J Public Health; 2012; 56(4):269-72. PubMed ID: 23354136 [TBL] [Abstract][Full Text] [Related]
17. Serologic status of women in an urban population in Brazil before and after rubella immunization campaign using routine screening data. Artimos de Oliveira S; Bastos Camacho LA; Uzeda Barreto MC; Coca Velarde LG; Siqueira MM J Infect Dis; 2011 Sep; 204 Suppl 2():S664-8. PubMed ID: 21954264 [TBL] [Abstract][Full Text] [Related]
18. Rubella immunity levels in the United States population: has the threshold of viral elimination been reached? Hyde TB; Kruszon-Moran D; McQuillan GM; Cossen C; Forghani B; Reef SE Clin Infect Dis; 2006 Nov; 43 Suppl 3():S146-50. PubMed ID: 16998774 [TBL] [Abstract][Full Text] [Related]
19. The epidemiology of rubella in England and Wales before and after the 1994 measles and rubella vaccination campaign: fourth joint report from the PHLS and the National Congenital Rubella Surveillance Programme. Miller E; Waight P; Gay N; Ramsay M; Vurdien J; Morgan-Capner P; Hesketh L; Brown D; Tookey P; Peckham C Commun Dis Rep CDR Rev; 1997 Feb; 7(2):R26-32. PubMed ID: 9046126 [TBL] [Abstract][Full Text] [Related]
20. Seroepidemiology study of rubella antibodies among pregnant women from seven Asian countries: evaluation of the rubella vaccination program in Taiwan. Tseng HF; Chang CK; Tan HF; Yang SE; Chang HW Vaccine; 2006 Jul; 24(29-30):5772-7. PubMed ID: 16759764 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]